Baseline characteristics of patients. by Su Hwan Park (15158181)

“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”

Effects of repeated intravenous esketamine administration on affective biases by Christine Reif-Leonhard (20516212)

“…</p> <p>66.7% participants who received at least five infusions (<i>n</i> = 12) showed significant improvement. Emotion recognition improved for all emotions except sadness, where accuracy decreased, particularly for low-intensity expressions (<i>p</i> = .007, d = −1.09). …”

Bidimensional High-Low Frequency (HF, LF) plane representation of the interaction among Phase and High-Low Authoritativeness Groups_.: In the Low Authority (LA) group the... by David Vagni (8060432)

Subjects:

Changes in best-corrected visual acuity and total area reduction ratio of the epiretinal membrane (ERM) during follow-up. by Su Hwan Park (15158181)

“…<p>(a) During the follow-up period, the stable group showed no significant change in visual acuity, whereas the progression group exhibited a decrease compared to baseline starting at 12 months, with greater changes than those in the stable group beginning at 6 months. …”

Normalized significant family changes in abundance. by Karley K. Mahalak (3212670)

“…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…”

S4 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

S3 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

S2 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

Thermal properties of alumina bioceramics. by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

S5 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

S6 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

S1 Data - by Zhen Wang (72451)

“…<div><p>The formation and distribution of residual stress during the micro-milling process significantly affect the crack resistance and service life of alumina bioceramics. …”

The effect of β-blocker treatment on renin (A) and aldosterone-to-renin ratio (B). by Ningning Wang (560944)

Subjects:

Complication subgroup analysis of the RAAS system in T2DM patients. by Ningning Wang (560944)

Subjects:

Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

Subjects:

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

Subjects:

The values of angiotensin II by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

Subjects:

General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects: